Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 16.67% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Communication Services | 10.86% |
| 5 | Consumer Staples | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFC
676
DELISTED
Premier Financial Corp. Common Stock
PFC
| $23.6M | 0.03% |
1,025,011
-160,531
| -14% | -$3.25M |
|
677
CRISPR Therapeutics
CRSP
$5.22B
| $23.5M | 0.03% |
153,200
-241,500
| -61% | -$28.5M |
|
678
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $23.4M | 0.03% |
940,219
-31,900
| -3% | -$752K |
|
|
SPTN
679
DELISTED
SpartanNash
SPTN
| $23.4M | 0.03% |
1,342,278
-346,500
| -21% | -$6.47M |
|
680
Towne Bank
TOWN
$3.5B
| $23.3M | 0.03% |
990,642
-171,041
| -15% | -$3.53M |
|
681
Community Health Systems
CYH
$419M
| $23.2M | 0.03% |
3,126,635
+1,457,675
| +87% | +$10.3M |
|
|
BMTC
682
DELISTED
Bryn Mawr Bank Corp
BMTC
| $23.2M | 0.03% |
758,420
-22,400
| -3% | -$654K |
|
683
NRC Health Common Stock
NRC
$471M
| $23.2M | 0.03% |
541,984
+4,184
| +0.8% | +$215K |
|
684
ManpowerGroup
MAN
$2.75B
| $23.2M | 0.03% |
256,752
-94,300
| -27% | -$7.75M |
|
|
CTB
685
DELISTED
Cooper Tire & Rubber Co.
CTB
| $23.1M | 0.03% |
571,479
-37,721
| -6% | -$1.44M |
|
686
Alpha and Omega Semiconductor
AOSL
$916M
| $23.1M | 0.03% |
976,800
+164,200
| +20% | +$3.35M |
|
687
10x Genomics
TXG
$7.58B
| $23M | 0.03% |
162,700
-133,400
| -45% | -$19.4M |
|
688
American Homes 4 Rent
AMH
$12.3B
| $23M | 0.02% |
765,529
-6,757
| -0.9% | -$198K |
|
689
Carter's
CRI
$1.44B
| $22.9M | 0.02% |
243,800
+137,000
| +128% | +$12.1M |
|
690
Portland General Electric
POR
$5.92B
| $22.9M | 0.02% |
535,593
-982,135
| -65% | -$40M |
|
691
Huazhu Hotels Group
HTHT
$12.5B
| $22.8M | 0.02% |
507,400
+281,800
| +125% | +$12.9M |
|
692
Ironwood Pharmaceuticals
IRWD
$674M
| $22.8M | 0.02% |
2,005,753
+1,088,000
| +119% | +$11.9M |
|
693
ArcBest
ARCB
$3.28B
| $22.7M | 0.02% |
532,239
+60,300
| +13% | +$2.29M |
|
|
FPRX
694
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $22.7M | 0.02% |
1,334,848
-361,338
| -21% | -$4.53M |
|
695
Eagle Materials
EXP
$6.41B
| $22.7M | 0.02% |
224,000
+72,800
| +48% | +$6.77M |
|
696
PennyMac Financial
PFSI
$4.13B
| $22.7M | 0.02% |
345,600
-118,300
| -26% | -$7.04M |
|
|
AXON
697
Axon Enterprise
AXON
$50B
| $22.7M | 0.02% |
184,952
+82,200
| +80% | +$9.43M |
|
698
KRONOS Worldwide
KRO
$996M
| $22.6M | 0.02% |
1,518,500
-62,500
| -4% | -$883K |
|
699
Weis Markets
WMK
$1.77B
| $22.6M | 0.02% |
472,136
-21,575
| -4% | -$1.04M |
|
700
Halozyme
HALO
$11.4B
| $22.6M | 0.02% |
528,129
+429
| +0.1% | +$15.4K |
|
Similar funds
Jim Simons's Q4 2020 Portfolio in Review
As of Q4 2020, Jim Simons held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in NVIDIA worth $524M.
- Jim Simons's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Jim Simons added most to Amazon in Q4 2020, an estimated $306M increase.
- Jim Simons's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Jim Simons fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Jim Simons's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Jim Simons opened 565 new positions and closed 555 in Q4 2020.
- Jim Simons's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.